Your browser doesn't support javascript.
loading
Cardiometabolic effects of a novel SIRT1 activator, SRT2104, in people with type 2 diabetes mellitus.
Noh, Radzi M; Venkatasubramanian, Sowmya; Daga, Shruti; Langrish, Jeremy; Mills, Nicholas L; Lang, Ninian N; Hoffmann, Ethan; Waterhouse, Brian; Newby, David E; Frier, Brian M.
Afiliación
  • Noh RM; Department of Diabetes, Royal Infirmary of Edinburgh, Edinburgh, UK.
  • Venkatasubramanian S; Department of Cardiovascular Research, University of Edinburgh, Edinburgh, UK.
  • Daga S; Clinical Development, GSK, Surrey, UK.
  • Langrish J; Department of Cardiovascular Research, University of Edinburgh, Edinburgh, UK.
  • Mills NL; Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, UK.
  • Lang NN; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
  • Hoffmann E; Research and Development, GlaxoSmithKline, Philadelphia, Pennsylvania, USA.
  • Waterhouse B; Research and Development, GlaxoSmithKline, Philadelphia, Pennsylvania, USA.
  • Newby DE; Division of Health Sciences, Centre for Cardiovascular Sciences, University of Edinburgh, Edinburgh, Edinburgh, UK.
  • Frier BM; Department of Diabetes, Royal Infirmary Edinburgh, NHS Lothian, Edinburgh, UK.
Open Heart ; 4(2): e000647, 2017.
Article en En | MEDLINE | ID: mdl-28912956
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Open Heart Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Open Heart Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido